# Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-stigma-symptom-management-cancer-survivors/
> **Published:** 2026-03-24T17:11:06-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:40:29-04:00
> **Clinical Summary:** Explore cannabis stigma symptom management among cancer survivors and patient perspectives on therapeutic use for symptom relief.

---

CED Clinical Relevance  #62Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
🔬 Evidence Watch  |  CED Clinic
CancerStigma[Symptom Management](https://cedclinic.com/amyotrophic-lateral-sclerosis-cannabis-guidelines-utah/)Patient PerspectivesOncology

Journal
[Supportive care](https://cedclinic.com/pediatric-oncology-supportive-care-cannabis-research-funding-iowa/) in cancer: official journal of the Multinational Association of [Supportive Care](https://cedclinic.com/pediatric-oncology-supportive-care-cannabis-research-funding-iowa/) in Cancer

Study Type
Observational Study

Population
Human participants

Why This Matters

Cancer survivors face complex [symptom management](https://cedclinic.com/amyotrophic-lateral-sclerosis-cannabis-guidelines-utah/) decisions, and perceived stigma can create barriers to discussing [cannabis therapeutics](https://cedclinic.com/firearms-regulatory-guidance-cannabis/) with their care teams. Understanding patient perspectives on cannabis stigma helps clinicians create more supportive environments for evidence-based symptom management discussions.

Clinical Summary
This mixed-methods study examined stigma perceptions among 23 cancer survivors in the Northeast U.S., including 10 cannabis users and 13 non-users. The sample demonstrated generally positive attitudes toward [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) for symptom management. Most participants reported feeling minimal stigma regarding [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and did not feel judged by their healthcare providers. Both cannabis users and non-users expressed acceptance or neutrality toward other cancer survivors using cannabis for symptom relief.

Dr. Caplan’s Take

“These findings align with what I observe clinically – cancer survivors tend to be pragmatic about symptom management tools, including cannabis, when conventional approaches fall short. The reported comfort with provider discussions suggests we’re making progress in normalizing these therapeutic conversations.”

Clinical Perspective
🧠 Clinicians should proactively create stigma-free environments for discussing [cannabis therapeutics](https://cedclinic.com/firearms-regulatory-guidance-cannabis/) with cancer survivors. The study suggests patients are more open to these conversations than providers might assume, emphasizing the importance of routine inquiry about cannabis use as part of comprehensive symptom management planning.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20stigma%20and%20symptom%20management%20considerations%20in%20cancer%20survivors%3A%20a%20mix...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41820694/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41820694/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20stigma%20and%20symptom%20management%20considerations%20in%20cancer%20survivors%3A%20a%20mix...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41820694/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41820694/](https://pubmed.ncbi.nlm.nih.gov/41820694/)

Table of Contents

- [FAQ](#FAQ)[Do cancer survivors experience stigma when using cannabis for symptom management?](#Do_cancer_survivors_experience_stigma_when_using_cannabis_for_symptom_management)
- [How do cancer survivors generally view cannabis as a treatment option?](#How_do_cancer_survivors_generally_view_cannabis_as_a_treatment_option)
- [Are healthcare providers supportive of cannabis use among cancer survivors?](#Are_healthcare_providers_supportive_of_cannabis_use_among_cancer_survivors)
- [What factors influence cancer survivors’ decisions about using cannabis?](#What_factors_influence_cancer_survivors8217_decisions_about_using_cannabis)
- [Should oncologists discuss cannabis use with their cancer patients?](#Should_oncologists_discuss_cannabis_use_with_their_cancer_patients)
- [Related](#Related)

## FAQ

#### Do cancer survivors experience stigma when using cannabis for symptom management?

According to this study of 23 cancer survivors, most participants did not report experiencing stigma related to cannabis use. The majority felt accepting or neutral about other cancer survivors using cannabis, regardless of their own usage status, and did not feel judged by their medical providers.

#### How do cancer survivors generally view cannabis as a treatment option?

The study found that cancer survivors generally held positive attitudes toward cannabis use. Participants indicated feeling empowered to pursue whatever treatments were necessary to improve their wellbeing, suggesting an open-minded approach to cannabis as a therapeutic option.

#### Are healthcare providers supportive of cannabis use among cancer survivors?

Based on patient perspectives in this study, most cancer survivors did not feel judged by their medical providers regarding cannabis use. This suggests that healthcare providers may be more accepting of cannabis use for symptom management in cancer care than previously assumed.

#### What factors influence cancer survivors’ decisions about using cannabis?

The study indicates that cancer survivors are primarily motivated by symptom management needs and feel empowered to make treatment decisions based on what helps them feel better. The relatively low stigma levels and positive attitudes suggest that social barriers may be less influential than clinical considerations.

#### Should oncologists discuss cannabis use with their cancer patients?

Given that cancer survivors in this study felt largely non-judged by providers and held positive attitudes toward cannabis, oncologists should consider proactively discussing cannabis as part of comprehensive symptom management. Open communication can help ensure safe, informed use and integration with other treatments.

{“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41820694/”, “about”: “supportive care cancer official journal multinational”, “isPartOf”: “Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Symptoms improve for cancer patients after cannabis extract use, study finds – leafie](https://cedclinic.com/symptoms-improve-for-cancer-patients-after-cannabis-extract-use-study-finds-leafie/)

Discover how cannabis extract use has been linked to symptom improvement in cancer patients, highlighting therapeutic potential.

[Read More](https://cedclinic.com/symptoms-improve-for-cancer-patients-after-cannabis-extract-use-study-finds-leafie/)

[Surveyed Cancer Patients Who Use Cannabis for Symptom Management Worry About Cost, Legality](https://cedclinic.com/cannabis-use-barriers-cancer-patients-symptom-management/)

Explore concerns cancer patients have regarding the cost and legality of cannabis for symptom management.

[Learn More](https://cedclinic.com/cannabis-use-barriers-cancer-patients-symptom-management/)

[Medical Cannabis Linked to Meaningful Pain-Related Improvements in Large Minnesota Study](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/)

Review findings from a large study showing significant pain relief benefits from [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) use.

[Discover Insights](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).